Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI - Results from OCUM trial
Publicat a: | European Journal of Radiology 147(2022)S. 110113 |
---|---|
Autors principals: | Stelzner, Sigmar (Autor), Ruppert, Reinhard (Autor), Winde, Günther (Autor) |
Format: | Article |
Idioma: | English |
Publicat: |
2022
|
Matèries: | |
Accés en línia: | https://doi.org/10.1016/j.ejrad.2021.110113 |
Publicació relacionada: | In:
European Journal of Radiology |
Ítems similars
-
MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma : Surgical Quality and Histopathological Outcome of the OCUM Trial
per: Kreis, Martin E., et al.
Publicat: (2020) -
Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy : Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial
per: Ruppert, Reinhard, et al.
Publicat: (2020) -
Microcirculation measurements: Barriers for use in clinical routine
per: Henzler, Dietrich, et al.
Publicat: (2017) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
per: Köhler, Thomas, et al.
Publicat: (2021) -
Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
per: Hawchar, Fatime, et al.
Publicat: (2022)